Fact Check: The settlement will end the Sacklers' ownership of Purdue Pharma and bar them from making, selling, or marketing opioids in the U.S.

Fact Check: "The settlement will end the Sacklers' ownership of Purdue Pharma and bar them from making, selling, or marketing opioids in the U.S."

What We Know

The Sackler family, owners of Purdue Pharma, has reached a historic settlement with all 55 U.S. attorneys general, which totals $7.4 billion. This settlement is designed to address the opioid crisis that Purdue's products have contributed to significantly. As part of the agreement, the Sacklers will relinquish their control over Purdue Pharma and will be barred from selling opioids in the United States (AG Sunday, AG Nessel, Letitia James). The settlement is structured to provide funds for addiction treatment and prevention efforts across various communities in the U.S. over the next 15 years (AG Nessel, AG Wilson).

Analysis

The claim that the settlement will end the Sacklers' ownership of Purdue Pharma and bar them from making, selling, or marketing opioids in the U.S. is supported by multiple reliable sources. The official announcements from various state attorneys general confirm that the settlement includes provisions that terminate the Sacklers' control over Purdue Pharma and prohibit them from engaging in the opioid market (AG Sunday, AG Nessel, AG Wilson).

Additionally, the settlement is described as the largest of its kind, reflecting a significant legal and financial consequence for the Sacklers and Purdue Pharma. The involvement of all 50 states and U.S. territories lends credibility to the settlement's legitimacy and the seriousness of the claims against Purdue Pharma (NPR).

However, it is essential to note that while the Sacklers will no longer control Purdue Pharma, the long-term implications of the settlement, including the effectiveness of the funds in addressing the opioid crisis, remain to be seen. The settlement's approval is contingent on bankruptcy court proceedings, which adds a layer of complexity to its implementation (AG Nessel, AG Wilson).

Conclusion

Verdict: True
The claim that the settlement will end the Sacklers' ownership of Purdue Pharma and bar them from making, selling, or marketing opioids in the U.S. is accurate. The settlement has been officially confirmed by multiple state attorneys general and includes explicit terms that fulfill the claim.

Sources

1. AG Sunday Announces Historic Settlement with Purdue Pharma and Sackler ...
2. 23-124 Harrington v. Purdue Pharma L.P. (06/27/24)
3. AG Nessel Signs On to $7.4 Billion Purdue Pharma ...
4. Letitia James - New York State Attorney General
5. Attorney General Alan Wilson announces $7.4 Billion settlement against ...
6. The Office of the Attorney General William Tong - CT.gov
7. The Bankruptcy of Purdue Pharma in the Wake of Big ...
8. Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement